Panacea Biotec inks pact with UNICEF for supply of Pentavalent Vaccine

18 Jan 2017 Evaluate

Panacea Biotec has entered into long term agreement (LTA) with UNICEF for supply of Pentavalent Vaccine (Easyfive-TT) in calendar year 2017 and also received a Notification from Pan American Health Organization (PAHO) for purchase of Pentavalent Vaccine (Easyfive-TT) in the event PAHO should have any requirements through December 31, 2019.

Total value of this expected business from UN Agencies is worth $20.475 million equivalent to around Rs 140 crore based on current exchange rate.

Panacea Biotec is one of the India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

344.65 -0.10 (-0.03%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×